A Phase 1 Open-Label Study to Evaluate the Effect of CYP450 and P-gp Inhibition and Induction on the Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male Subjects

Conditions:   Pharmacology, Clinical;   HealthyInterventions:   Drug: Pomalidomide;   Drug: Ketoconazole;   Drug: Fluvoxamine;   Drug: CarbamazepineSponsors:   Celgene Corporation;   Celgene CorporationCompleted - verified November 2012
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials